200,000+ products from a single source!

sales@angenechem.com

Home > Imidazoles > 4311-88-0

4311-88-0

4311-88-0 | 5-(1H-INDOL-3-YLMETHYL)-3-METHYL-2-THIOXO-4-IMIDAZOLIDINONE

CAS No: 4311-88-0 Catalog No: AG00D9QV MDL No:MFCD00056916

Product Description

Catalog Number:
AG00D9QV
Chemical Name:
5-(1H-INDOL-3-YLMETHYL)-3-METHYL-2-THIOXO-4-IMIDAZOLIDINONE
CAS Number:
4311-88-0
Molecular Formula:
C13H13N3OS
Molecular Weight:
259.3268
MDL Number:
MFCD00056916
IUPAC Name:
5-(1H-indol-3-ylmethyl)-3-methyl-2-sulfanylideneimidazolidin-4-one
InChI:
InChI=1S/C13H13N3OS/c1-16-12(17)11(15-13(16)18)6-8-7-14-10-5-3-2-4-9(8)10/h2-5,7,11,14H,6H2,1H3,(H,15,18)
InChI Key:
TXUWMXQFNYDOEZ-UHFFFAOYSA-N
SMILES:
S=C1NC(C(=O)N1C)Cc1c[nH]c2c1cccc2

Properties

Complexity:
373  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
259.078g/mol
Formal Charge:
0
Heavy Atom Count:
18  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
259.327g/mol
Monoisotopic Mass:
259.078g/mol
Rotatable Bond Count:
2  
Topological Polar Surface Area:
80.2A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
XLogP3:
1.9  

Literature

Title Journal
Mechanical force-mediated pathological cartilage thinning is regulated by necroptosis and apoptosis. Osteoarthritis and cartilage 20170801
Necroptosis contributes to methamphetamine-induced cytotoxicity in rat cortical neurons. Toxicology in vitro : an international journal published in association with BIBRA 20160901
FTY720 induces autophagy-related apoptosis and necroptosis in human glioblastoma cells. Toxicology letters 20150702
The role of RIP3 mediated necroptosis in ouabain-induced spiral ganglion neurons injuries. Neuroscience letters 20140822
Role of receptor interacting protein (RIP)1 on apoptosis-inducing factor-mediated necroptosis during acetaminophen-evoked acute liver failure in mice. Toxicology letters 20140321
Akt and mTOR mediate programmed necrosis in neurons. Cell death & disease 20140201
The molecular mechanisms and gene expression profiling for shikonin-induced apoptotic and necroptotic cell death in U937 cells. Chemico-biological interactions 20130925
Cobalt triggers necrotic cell death and atrophy in skeletal C2C12 myotubes. Toxicology and applied pharmacology 20130901
Identification of potent Yes1 kinase inhibitors using a library screening approach. Bioorganic & medicinal chemistry letters 20130801
Necrostatin-1 blocks both RIPK1 and IDO: consequences for the study of cell death in experimental disease models. Cell death and differentiation 20130201
The targeted inhibition of mitochondrial Hsp90 overcomes the apoptosis resistance conferred by Bcl-2 in Hep3B cells via necroptosis. Toxicology and applied pharmacology 20130101
RIP1-mediated mitochondrial dysfunction and ROS production contributed to tumor necrosis factor alpha-induced L929 cell necroptosis and autophagy. International immunopharmacology 20121201
Necrostatin-1 protects photoreceptors from cell death and improves functional outcome after experimental retinal detachment. The American journal of pathology 20121101
Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models. Cell death & disease 20121101
Staurosporine induces apoptosis and necroptosis in cultured rat astrocytes. Drug and chemical toxicology 20121001
Necrostatin-1 attenuates mitochondrial dysfunction in neurons and astrocytes following neonatal hypoxia-ischemia. Neuroscience 20120906
Fluorescence polarization assay for inhibitors of the kinase domain of receptor interacting protein 1. Analytical biochemistry 20120815
Necroptosis contributes to the cyclosporin A-induced cytotoxicity in NRK-52E cells. Die Pharmazie 20120801
Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo. Basic research in cardiology 20120701
Necroptosis modulated by autophagy is a predominant form of melanoma cell death induced by sanguilutine. Biological chemistry 20120701
Fas ligand-Fas signaling participates in light-induced apoptotic death in photoreceptor cells. Investigative ophthalmology & visual science 20120601
PI3K inhibitor D-116883 is effective in in vitro models of ovarian cancer. Anticancer research 20120501
Intermediate domain of receptor-interacting protein kinase 1 (RIPK1) determines switch between necroptosis and RIPK1 kinase-dependent apoptosis. The Journal of biological chemistry 20120427
Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury. Kidney international 20120401
Heme induces programmed necrosis on macrophages through autocrine TNF and ROS production. Blood 20120308
Glutamate oxidative injury to RGC-5 cells in culture is necrostatin sensitive and blunted by a hydrogen sulfide (H2S)-releasing derivative of aspirin (ACS14). Neurochemistry international 20120301
Nec-1 enhances shikonin-induced apoptosis in leukemia cells by inhibition of RIP-1 and ERK1/2. International journal of molecular sciences 20120101
RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome. Immunity 20111223
Water-soluble germanium nanoparticles cause necrotic cell death and the damage can be attenuated by blocking the transduction of necrotic signaling pathway. Toxicology letters 20111215
Necroptosis is a novel mechanism of radiation-induced cell death in anaplastic thyroid and adrenocortical cancers. Surgery 20111201
NO donor induces Nec-1-inhibitable, but RIP1-independent, necrotic cell death in pancreatic β-cells. FEBS letters 20111003
Discrimination between primary necrosis and apoptosis by necrostatin-1 in Annexin V-positive/propidium iodide-negative cells. Biochemical and biophysical research communications 20110805
24(S)-hydroxycholesterol induces neuronal cell death through necroptosis, a form of programmed necrosis. The Journal of biological chemistry 20110715
MicroRNA-155 prevents necrotic cell death in human cardiomyocyte progenitor cells via targeting RIP1. Journal of cellular and molecular medicine 20110701
The dual functions of receptor interacting protein 1 in fas-induced hepatocyte death during sepsis. Shock (Augusta, Ga.) 20110501
Light- and sodium azide-induced death of RGC-5 cells in culture occurs via different mechanisms. Apoptosis : an international journal on programmed cell death 20110401
Necrostatin decreases oxidative damage, inflammation, and injury after neonatal HI. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20110101
RIP1-dependent and independent effects of necrostatin-1 in necrosis and T cell activation. PloS one 20110101
Cyclophilin A release as a biomarker of necrotic cell death. Cell death and differentiation 20101201
Synergistic protective effects of humanin and necrostatin-1 on hypoxia and ischemia/reperfusion injury. Brain research 20101008
The role of PARP activation in glutamate-induced necroptosis in HT-22 cells. Brain research 20100709
Necroptosis, a novel form of caspase-independent cell death, contributes to neuronal damage in a retinal ischemia-reperfusion injury model. Journal of neuroscience research 20100515
Nitration of the mitochondrial complex I subunit NDUFB8 elicits RIP1- and RIP3-mediated necrosis. Free radical biology & medicine 20100115
Novel interventions targeting on apoptosis and necrosis induced by aluminum chloride in neuroblastoma cells. Journal of biological regulators and homeostatic agents 20100101
Enhanced tissue integration during cartilage repair in vitro can be achieved by inhibiting chondrocyte death at the wound edge. Tissue engineering. Part A 20090701
Attenuation of cadmium-induced necrotic cell death by necrostatin-1: potential necrostatin-1 acting sites. Toxicology and applied pharmacology 20090301
3-Nitrofluoranthene (3-NF) but not 3-aminofluoranthene (3-AF) elicits apoptosis as well as programmed necrosis in Hepa1c1c7 cells. Toxicology 20090131
Necroptosis contributes to the NMDA-induced excitotoxicity in rat's cultured cortical neurons. Neuroscience letters 20081212
Structure-activity relationship and liver microsome stability studies of pyrrole necroptosis inhibitors. Bioorganic & medicinal chemistry letters 20080601
Identification of RIP1 kinase as a specific cellular target of necrostatins. Nature chemical biology 20080501
Acute myeloid leukemia-targeted toxin activates both apoptotic and necroptotic death mechanisms. PloS one 20080101
Necrostatin-1 protects against glutamate-induced glutathione depletion and caspase-independent cell death in HT-22 cells. Journal of neurochemistry 20071201
The cardioprotective effect of necrostatin requires the cyclophilin-D component of the mitochondrial permeability transition pore. Cardiovascular drugs and therapy 20071201
Necrostatin: a potentially novel cardioprotective agent? Cardiovascular drugs and therapy 20070801
Sitosterol-containing lipoproteins trigger free sterol-induced caspase-independent death in ACAT-competent macrophages. The Journal of biological chemistry 20061103
Structure-activity relationship study of novel necroptosis inhibitors. Bioorganic & medicinal chemistry letters 20051115
Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nature chemical biology 20050701
Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. Nature medicine 20050301
Structural requirements for hydantoins and 2-thiohydantoins to induce lymphoproliferative popliteal lymph node reactions in the mouse. International journal of immunopharmacology 19880101

Related Products

© 2019 Angene International Limited. All rights Reserved.